Title | Type | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | %Female (2001) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cancer Research | journal | 4.432 Q1 | 498 | 1377 | 3054 | 53308 | 27535 | 3036 | 8.60 | 38.71 | 31.90 | |
2 | International Journal of Cancer | journal | 1.815 Q1 | 260 | 691 | 2198 | 24711 | 9305 | 2125 | 4.24 | 35.76 | 29.48 | |
3 | Cancer | journal | 1.593 Q1 | 340 | 777 | 2445 | 24698 | 9828 | 2278 | 3.93 | 31.79 | 28.65 | |
4 | Clinical Cancer Research | journal | 2.121 Q1 | 377 | 605 | 1599 | 22457 | 8468 | 1549 | 5.08 | 37.12 | 30.52 | |
5 | Journal of Clinical Oncology | journal | 4.111 Q1 | 624 | 650 | 1728 | 18740 | 16235 | 1468 | 8.86 | 28.83 | 29.68 | |
6 | International Journal of Radiation Oncology Biology Physics | journal | 1.722 Q1 | 277 | 571 | 1594 | 16161 | 5660 | 1452 | 3.30 | 28.30 | 23.50 | |
7 | Experimental Hematology | journal | 0.674 Q2 | 129 | 170 | 978 | 7922 | 1564 | 956 | 3.15 | 46.60 | 32.20 | |
8 | Cancer Genetics and Cytogenetics | journal | 0.639 Q2 | 78 | 247 | 821 | 6362 | 1212 | 738 | 1.49 | 25.76 | 42.60 | |
9 | Cancer Science | journal | 0.834 Q2 | 166 | 183 | 588 | 5722 | 1261 | 581 | 2.10 | 31.27 | 13.61 | |
10 | Cancer Investigation | journal | 0.666 Q2 | 93 | 100 | 296 | 5254 | 453 | 254 | 1.50 | 52.54 | 26.80 | |
11 | Breast Cancer Research and Treatment | journal | 1.307 Q1 | 177 | 585 | 491 | 5068 | 1469 | 483 | 2.55 | 8.66 | 38.52 | |
12 | Advances in Cancer Research | journal | 6.501 Q1 | 109 | 26 | 41 | 4927 | 557 | 41 | 11.22 | 189.50 | 22.00 | |
13 | Genes Chromosomes and Cancer | journal | 2.310 Q1 | 130 | 152 | 468 | 4822 | 2222 | 456 | 4.48 | 31.72 | 38.26 | |
14 | Current Opinion in Oncology | journal | 1.076 Q1 | 104 | 102 | 333 | 4271 | 847 | 302 | 2.62 | 41.87 | 27.89 | |
15 | Anti-Cancer Drugs | journal | 0.514 Q3 | 102 | 131 | 370 | 4095 | 644 | 369 | 1.65 | 31.26 | 21.81 | |
16 | Nutrition and Cancer | journal | 0.879 Q2 | 130 | 99 | 291 | 4035 | 777 | 286 | 2.49 | 40.76 | 38.60 | |
17 | Molecular Cancer Research | journal | 2.769 Q1 | 153 | 66 | 255 | 3826 | 1148 | 255 | 3.51 | 57.97 | 36.36 | |
18 | Cancer journal (Sudbury, Mass.) | journal | 1.148 Q1 | 102 | 90 | 279 | 3702 | 615 | 211 | 1.94 | 41.13 | 26.09 | |
19 | Nuclear Medicine and Biology | journal | 0.749 Q2 | 98 | 120 | 372 | 3536 | 670 | 368 | 1.78 | 29.47 | 23.25 | |
20 | Breast | journal | 0.236 | 98 | 146 | 232 | 3523 | 119 | 212 | 0.39 | 24.13 | 34.21 | |
21 | Oncologist | journal | 0.713 Q2 | 189 | 113 | 226 | 3430 | 435 | 191 | 2.26 | 30.35 | 27.65 | |
22 | Drug Resistance Updates | journal | 0.727 Q2 | 132 | 42 | 155 | 3286 | 324 | 146 | 1.77 | 78.24 | 30.12 | |
23 | Seminars in Cancer Biology | journal | 2.998 Q1 | 179 | 52 | 120 | 3283 | 686 | 120 | 4.87 | 63.13 | 30.43 | |
24 | Journal of Mammary Gland Biology and Neoplasia | journal | 1.449 Q1 | 112 | 42 | 117 | 3151 | 392 | 112 | 3.06 | 75.02 | 44.68 | |
25 | Molecular Carcinogenesis | journal | 1.521 Q1 | 107 | 73 | 292 | 3045 | 967 | 289 | 3.41 | 41.71 | 34.42 | |
26 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.412 Q3 | 90 | 138 | 415 | 2943 | 528 | 404 | 1.21 | 21.33 | 21.99 | |
27 | Neoplasia | journal | 1.694 Q1 | 144 | 61 | 113 | 2688 | 432 | 111 | 3.82 | 44.07 | 31.12 | |
28 | European Journal of Cancer Prevention | journal | 0.647 Q2 | 88 | 90 | 253 | 2408 | 496 | 229 | 1.80 | 26.76 | 33.62 | |
29 | Melanoma Research | journal | 0.864 Q2 | 80 | 85 | 238 | 2390 | 480 | 225 | 1.90 | 28.12 | 32.43 | |
30 | Oncology | journal | 0.376 Q3 | 83 | 259 | 916 | 2375 | 893 | 879 | 0.94 | 9.17 | 24.23 | |
31 | Nitric Oxide - Biology and Chemistry | journal | 0.859 Q2 | 110 | 63 | 140 | 2266 | 308 | 138 | 1.81 | 35.97 | 33.81 | |
32 | Seminars in Radiation Oncology | journal | 1.263 Q1 | 103 | 39 | 135 | 2168 | 421 | 125 | 2.96 | 55.59 | 29.27 | |
33 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.492 Q3 | 68 | 58 | 170 | 1918 | 256 | 152 | 1.53 | 33.07 | 27.49 | |
34 | Tumor Biology | journal | 0.516 Q3 | 101 | 53 | 149 | 1670 | 197 | 147 | 1.08 | 31.51 | 21.54 | |
35 | Cytotherapy | journal | 0.273 Q3 | 105 | 56 | 104 | 1610 | 70 | 91 | 0.67 | 28.75 | 34.67 | |
36 | Clinical Lung Cancer | journal | 0.165 Q4 | 74 | 54 | 39 | 1472 | 8 | 29 | 0.21 | 27.26 | 29.03 | |
37 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 59 | 16 | 17 | 1465 | 12 | 17 | 0.80 | 91.56 | 25.00 | ||
38 | Clinical Breast Cancer | journal | 0.179 Q4 | 80 | 49 | 38 | 1460 | 11 | 36 | 0.29 | 29.80 | 33.65 | |
39 | Current Problems in Cancer | journal | 0.188 Q4 | 47 | 11 | 41 | 1447 | 21 | 35 | 0.36 | 131.55 | 25.00 | |
40 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.162 Q4 | 65 | 46 | 32 | 1290 | 14 | 31 | 0.44 | 28.04 | 27.72 | |
41 | Journal of the National Cancer Institute. Monographs | journal | 1.212 Q1 | 95 | 46 | 77 | 1192 | 279 | 73 | 3.16 | 25.91 | 32.14 | |
42 | Journal of Immunotherapy | journal | 0.874 Q2 | 106 | 37 | 142 | 1157 | 355 | 135 | 2.31 | 31.27 | 35.98 | |
43 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 8 | 28 | 1020 | 1 | 28 | 0.05 | 127.50 | 15.71 | ||
44 | Oncology Research | journal | 0.682 Q2 | 76 | 33 | 346 | 1011 | 722 | 343 | 1.96 | 30.64 | 34.10 | |
45 | Journal of Immunotherapy | journal | 47 | 31 | 73 | 988 | 186 | 73 | 2.13 | 31.87 | 31.45 | ||
46 | Medical Oncology | journal | 0.432 Q3 | 90 | 38 | 159 | 949 | 232 | 154 | 1.43 | 24.97 | 34.08 | |
47 | Molecular Cancer Therapeutics | journal | 199 | 17 | 0 | 801 | 0 | 0 | 0.00 | 47.12 | 37.50 | ||
48 | Cancer Immunology Research | journal | 134 | 11 | 0 | 330 | 0 | 0 | 0.00 | 30.00 | 19.23 | ||
49 | Recent Results in Cancer Research | book series | 0.682 Q2 | 63 | 25 | 213 | 270 | 368 | 213 | 1.94 | 10.80 | 26.60 | |
50 | Advances in Oncobiology | book series | 0.124 Q4 | 3 | 0 | 23 | 0 | 2 | 20 | 0.09 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®